Companies have long lamented Europe’s fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.
原文: https://www.cnbc.com/2026/04/11/trump-pharma-tariffs-mfn-china-europe-biotech-stocks.html
Last Update:
11 4 月, 2026
